Orthofix Medical Inc. Additional Paid in Capital, Common Stock
Orthofix Medical Inc. (OFIX) had Additional Paid in Capital, Common Stock of $830.42 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-05
- 2026-06-30: Additional Paid in Capital, Common Stock $830.42M.
- 2026-03-31: Additional Paid in Capital, Common Stock $820.25M.
- 2025-12-31: Additional Paid in Capital, Common Stock $813.77M.
- 2025-09-30: Additional Paid in Capital, Common Stock $804.01M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $830.42M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $820.25M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $813.77M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $804.01M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $796.81M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $786.17M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $779.72M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $770.00M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $764.54M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $753.40M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $746.45M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $741.64M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $735.53M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $721.14M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $334.97M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $328.39M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $323.74M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $318.21M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $313.95M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $307.78M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $302.74M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $297.63M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $292.29M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $285.20M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $282.29M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $275.69M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $271.02M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $263.06M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $257.89M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $252.86M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $243.16M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $238.42M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $233.74M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $228.36M 10-Q · filed 2018-04-30 | |
| 2017-12-31 | $220.59M 10-K · filed 2019-02-25 | |
| 2017-09-30 | $215.78M 10-Q · filed 2017-10-30 | |
| 2017-06-30 | $211.99M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $208.69M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $204.09M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $208.11M 10-Q · filed 2016-10-31 | |
| 2016-06-30 | $205.34M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $212.72M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $232.13M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $239.95M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $237.99M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $236.26M 10-Q · filed 2015-05-18 | |
| 2014-12-31 | $232.79M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $231.04M 10-Q · filed 2015-03-31 | |
| 2014-06-30 | $228.50M 10-Q · filed 2015-03-31 | |
| 2014-03-31 | $223.36M 10-Q/A · filed 2015-03-31 | $223.63M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $216.65M 10-K · filed 2015-04-29 | |
| 2013-09-30 | $215.08M 10-Q · filed 2014-03-25 | |
| 2013-06-30 | $225.15M 10-Q · filed 2014-03-24 | |
| 2013-03-31 | $250.38M 10-Q/A · filed 2014-03-24 | $250.19M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $246.31M 10-K/A · filed 2015-03-31 | $246.11M 10-K · filed 2013-03-01 |
| 2012-09-30 | $246.05M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $231.76M 10-Q · filed 2012-07-30 | |
| 2012-03-31 | $222.79M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $214.50M 10-K/A · filed 2014-03-24 | $214.31M 10-K · filed 2012-02-29 |
| 2011-09-30 | $220.64M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $213.29M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $195.40M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |